首页> 外文期刊>Bone marrow transplantation >Allogeneic stem cell transplantation from unrelated donor for class 3 beta-thalassemia major using reduced-intensity conditioning regimen.
【24h】

Allogeneic stem cell transplantation from unrelated donor for class 3 beta-thalassemia major using reduced-intensity conditioning regimen.

机译:使用降低强度的调节方案,从无关的供体进行3类β地中海贫血的同种异体干细胞移植。

获取原文
获取原文并翻译 | 示例
       

摘要

beta-thalassemia major is a genetic disorder resulting in absent or reduced beta globin chain synthesis producing hemolytic anemia. Currently, the only cure for thalassemia is allogeneic stem cell transplantation, which corrects the genetic defect in the hematopoietic system by the use of allogeneic stem cells. According to Pesaro classification, patients with thalassemia major can be categorized into three classes of risk for marrow transplantation, and patients with class 3 who had evidence of organ damage from iron-overload had poor outcomes, and were more likely to experience transplant-related mortality or disease recurrence. One approach to reduce transplant-related mortality is to use reduced-intensity stem cell transplantation (RIST) and here we report the successful transplantation from 6/6 matched unrelated donors using reduced-intensity conditioning for two children with class 3 thalassemia major who had evidence of organ damage.
机译:严重的β地中海贫血是一种遗传性疾病,导致缺乏或减少的β珠蛋白链合成,导致溶血性贫血。目前,地中海贫血的唯一治愈方法是同种异体干细胞移植,该移植可通过使用同种异体干细胞纠正造血系统的遗传缺陷。根据Pesaro的分类,重度地中海贫血患者可分为三类骨髓移植风险,而三类有铁超负荷导致器官损害证据的患者预后较差,更有可能发生与移植相关的死亡或疾病复发。降低移植相关死亡率的一种方法是使用降低强度的干细胞移植(RIST),在这里我们报道了使用降低强度的条件从6/6个匹配的无关亲戚供体成功移植了两名有证据的3级地中海贫血严重儿童器官损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号